Orphan Drugs Market by Disease Type and Indication Forecasts to 2022
Orphan Drugs Market report, published by Allied Market Research, forecasts that the global market was valued at $106 billion in 2015 and is expected to garner $169 billion by 2022, registering a CAGR of 6.8% during the forecast period 2016 - 2022. The oncology disease segment held nearly one-thirds of the market share in 2015.
View full press release